In pursuit of innovative excellence, new business models, and competitive advantages, pharmaceutical companies are entering into collaborative models that are firmly anchored in the industry’s DNA. The cloud plays a considerable role, as it enables collaboration across companies. On one hand, companies are forging partnerships with external institutions such as clinics, laboratories, and research centers. On the other hand, they are investing heavily in mergers and acquisitions. Mergers & acquisitions (M&A) boost growth, quickly exploit innovation potential, and better meet increasing regulatory requirements.
Read more to know how to maintain and build on competitiveness in the pharmaceutical industry with zero trust and a cloud-based security platform.
